Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-27T13:50:06.606Z Has data issue: false hasContentIssue false

A Patient with Neurosarcoidosis

Published online by Cambridge University Press:  02 December 2014

Taim Muayqil
Affiliation:
Department of Neurology, University of Alberta, Edmonton, AB, Canada
M.S. Hussain
Affiliation:
Department of Neurology, University of Alberta, Edmonton, AB, Canada
Maher Saqqur
Affiliation:
Department of Neurology, University of Alberta, Edmonton, AB, Canada
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A previously well 35-year-old male presented with a one month history of generalized progressive headaches, mental status changes, and behavioral changes in the form of aggression and somnolence. His initial physical examination was unremarkable apart from bilateral papilledema and delirium. Investigations, including complete blood count (CBC), urea, creatinine, electrolytes, erythrocyte sedimentation rate (ESR), liver function tests (LFT), thyroid stimulating hormone (TSH), EKG, and chest x-ray, were within normal limits. An immediate computed tomogram (CT) scan of the head showed acute hydrocephalus. A shunt was inserted, and a CSF sample was obtained. It showed an elevated cell count (WBC 26x109 cells/L, 82% lymphocytes) and elevated protein (7.05 g/L). The CSF staining for AFB was negative, as were the bacterial and viral cultures. Cytological and fungal staining was also negative. Weighted with gadolinium, T1 and FLAIR MRI sequences displayed an extensive white matter abnormality with prominent meningeal and hypothalamic enhancement (Figure 1). Tuberculosis (TB) was the main diagnostic consideration. Sarcoidosis, lymphoma and lepto-meningeal metastasis were also considered. The CSF cytology was negative on two occasions, making a neoplastic cause less likely. Tuberculosis was felt to be the most likely etiological diagnosis, as there were no systemic findings of sarcoidosis on his initial presentation.

Type
Neuroimaging Highlight
Copyright
Copyright © The Canadian Journal of Neurological 2006

References

1. Sharma, OP. Sarcoidosis. Dis Mon. 1990. 39(9):472535.Google Scholar
2. Allen, RK, Sellars, RE, Sandstrom, PA. A prospective study of 32patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003 Jun. 20(2): 118–25.Google Scholar
3. Delaney, P. Neurologic manifestations in sarcoidosis: review ofliterature, with a report of 23 cases. Ann Intern Med. 77; 87(3): 336–45.CrossRefGoogle Scholar
4. Chapelon, C, Ziza, JM, Piette, JC, et al. Neurosarcoidosis: signscourse and treatment in 35 confirmed cases. Medicine. 1990; 69:261–76.Google Scholar
5. Spencer, TS, Campellone, JV, Maldonado, I, Huang, N, Usmani, Q, Reginato, AJ. Semin clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Arthritis Rheum. Feb 2005; 34: 649–61.Google ScholarPubMed
6. Christoforidis, GA, Spickler, EM, Recio, MV, Mehta, BM. MR of CNS Sarcoidosis: Correlation of imaging features to clinical symptoms and response to treatment. AJNR Am. J. Neuroradiol. 1999; Apr 20: 655–69.Google Scholar
7. Sharma, OP. FCCP Neurosarcoidosis: A personal perspective basedon the study of 37 patients. Chest. 1997; 112: 220–8.CrossRefGoogle Scholar
8. Moore, FGA, Andermann, F, Richardson, J, et al. The role of MRI andnerve root biopsy in the diagnosis of neurosarcoidosis. Can J Neurol Sci. 2001; 28: 349–53.Google Scholar
9. Maroun, FB, O’Dea, FJ, Mathieson, G, et al. Sarcoidosis Presentingas an intramedullary spinal cord lesion. Can J Neurol Sci. 2001; 28: 163–6.Google Scholar
10. Larner, AJ, Ball, JA, Howard, RS. Sarcoid tumor: continuingdiagnostic problems in the MRI era. J Neurol Neurosurg Psychiatry. 1999 Apr; 66(4): 510–2.Google Scholar
11. Sharma, MC, Arora, R, Mahapatra, AK, Sarat-Chandra, P, GaikwadSB, Sarkar, C. Intrasellar tuberculoma--an enigmatic pituitary infection: a series of 18 cases. Clin Neurol Neurosurg. 2000 Jun; 102(2): 72–7.CrossRefGoogle ScholarPubMed
12. Sharma, OP. Neurosarcoidosis: a personal perspective based on thestudy of 37 patients. Chest. 1997 Jul; 112(1): 220–8.CrossRefGoogle Scholar
13. Nowak, DA, Widenka, DC. Neurosarcoidosis: a review of itsintracranial manifestations, J Neurol. 2001; 248: 363–72.Google Scholar
14. Zajicek, JP, Scolding, NJ, Foster, O, Rovaris, M, et al. Central nervoussystem sarcoidosis—diagnosis and management. Q J Med. 1999; 92: 103–17.Google Scholar